The University of Hong Kong
Hong Kong
NCT Number: NCT07332624
This pilot study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment, and to investigate the feasibility and effectiveness of the intervention.
Interested in participating?
Request Info50 year and older
All sexes
Interventional
Not applicable
Hong Kong
Control Group:
The control group will receive instant messages about mental health management from HKSAR Government website (https://www.shallwetalk.hk/en/mental-well-being/mental-well-being-is-related-to-you/), which is open to the public.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in intervention group will receive the EMI for 8 weeks. Based on the steps of mobile message development recommended by Abroms, et al., we will develop a message content library and protocol for EMI delivery.
Time frame: 8 weeks
The primary outcome will be MBI-C scores to assess NPSs. A higher MBI-C scores will indicate a higher level of neuropsychiatric symptoms.
Time frame: 8 weeks
Each item was scored on a 4-point scale (0 "not at all" to 3 "nearly every day"). The total score is calculated by summing up the score of all items (range 0-27). High scores indicate worse depressive symptoms.
Time frame: 8 weeks
A 7-item scale with score ranging from 0 to 21, higher scores indicate higher severity of anxiety symptom
Time frame: 8 weeks
The total score is calculated by summing up the score of all items. Higher scores indicate better cognitive function.
Time frame: 8 weeks
AAQ-II is a measure of psychological flexibility. Each item is rated on a 7-point scale from 1 = never true to 7 = always true. Scores range from 1-49. A lower score indicates a lower level of psychological flexibility.
The University of Hong Kong
Other
Instant Message-delivered Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons Living With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial
Acronym: iact
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07691918
Cognition Disorders, Cognitive Dysfunction
Roanoke, Virginia, United States
View Trial DetailsNCT07594665
Alzheimer Disease, Alzheimer's Dementia (AD)
Charlottesville, Virginia, United States
View Trial DetailsNCT07558785
Alzheimer Disease, Alzheimer Disease (AD)
Pilsen, Czechia
View Trial DetailsNCT07519798
Cognition Disorders, Cognitive Dysfunction
Shanghai, Shanghai Municipality, China
View Trial Details